Abstract:The purpose of this study is to compare the ability of [68Ga]Ga-DOTA-FAPI-04 PET/CT and [18F]FDG PET/CT to stratify the malignancy and invasiveness of thymic epithelial tumours (TETs). From April 2021 to November 2022, participants with suspected TETs confirmed by histopathology or follow-up imaging were prospectively analysed. All participants underwent [18F]FDG and [68Ga]Ga-DOTA-FAPI-04 PET/CT within 1 week. Clinical characteristics, CT features, and metabolic parameters (maximum standardized uptake value [SUVmax] and tumour-to-mediastinum ratio [TMR]) of subjects with different pathological types and stages were compared. The diagnostic capacities of [18F]FDG and [68Ga]Ga-DOTA-FAPI-04 PET/CT were compared using receiver operating characteristic (ROC) curves and McNemar’s test. Fifty-seven participants were included. [68Ga]Ga-DOTA-FAPI-04 PET/CT was superior to [18F]FDG PET/CT in differentiating thymomas from thymic carcinomas (TCs) (AUC: 0.99 vs. 0.90, P = 0.02). Logistic regression revealed that SUVmax-FAPI (P = 0.04) was a significant predictive factor for TCs. SUVmax-FAPI and TMR-FAPI showed an excellent ability to differentiate low-risk thymomas (types A, AB, and B1), high-risk thymomas (types B2 and B3), and TCs (both P < 0.001). In thymomas, only SUVmax-FAPI (P < 0.001), TMR-FAPI (P < 0.001), and nonsmooth edges (P = 0.02) were significantly higher in the advanced-stage (Masaoka-Koga [MK] stage III/IV) group than in the early-stage group (MK stage I/II). Compared with [18F]FDG PET/CT, [68Ga]Ga-DOTA-FAPI-04 PET/CT showed significantly higher specificity (67 https://www.chictr.org.cn/com/25/showproj.aspx?proj=61192

Thymic Squamous Cell Carcinoma Mimicking Lymphoma on 68Ga-Fapi PET/CT

Thymic Small Cell Neuroendocrine Carcinoma Displayed on F-18-Fdg Pet/Ct Imaging

Thymic Small Cell Neuroendocrine Carcinoma Displayed on 18F-FDG PET/CT Imaging.

68Ga-FAPI PET/CT Detected Non–FDG-Avid Gastric Stromal Tumor

Pleural Spindle Cell Sarcoma on 68 Ga-DOTA-FAPI-04 PET/CT and 18 F-FDG PET/CT : A Rare Case

Superiority of [68Ga]ga-Dota-fapi-04 PET/CT to [18F]FDG PET/CT in the Evaluation of Thymic Epithelial Tumours.

18F-FDG PET/CT Versus 68Ga-FAPI PET/CT in a Case of Isolated Nodal-Type Follicular Dendritic Cell Sarcoma

Increased 68Ga-FAPI Uptake in Pulmonary Sclerosing Pneumocytoma

Increased 68Ga-Fapi Uptake by Mediastinal Benign Teratoma on 68Ga-Fapi PET/CT.

Epithelial Malignant Pleural Mesothelioma Mimics Lymphoma on 18F-FDG PET/MRI: A Case Report

68Ga-FAPI and 18F-FDG PET/CT Images in a Patient With Extrapulmonary Tuberculosis Mimicking Malignant Tumor

68Ga-Fapi PET/CT Detection of Non–FDG-Avid Poorly Differentiated Adenocarcinoma of the Trachea

A Case Report: Systemic Lymph Node Tuberculosis Mimicking Lymphoma on 18F-FDG PET/CT

68Ga-FAPI–Avid Submental Ectopic Papillary Thyroid Carcinoma and Lateral Neck Lymphadenopathy With Low 18F-FDG Uptake

Increased 68 Ga-FAPI Uptake in Pulmonary Sclerosing Pneumocytoma

Metastatic Papillary Thyroid Cancer Mimicking Hypopharyngeal Carcinoma

Primary Pancreatic Lymphoma Masquerading As Carcinoma on 18F-FDG PET/CT

68Ga-FAPI PET/CT Imaging of Graves Ophthalmopathy in a Patient With Esophageal Cancer

Ga-68-FAPI PET/CT Detected Non-FDG-Avid Gastric Stromal Tumor

False-Negative 68Ga-FAPI PET/CT in Pediatric Thyroid Medullary Carcinoma Seen With 68Ga-DOTATOC PET/CT and 18F-FDG PET/CT

Gastric Ulcer Mimicking Malignancy on FDG PET/CT.